Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Consulting agrmnt Appointed COO
|
Immune Therapeutics, Inc. (IMUN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/22/2023 |
4
| Farmer Glen A (CFO) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
| Bought 409,000 shares
@ $0.045, valued at
$18.4k
|
|
06/04/2021 |
4
| Griffin Noreen (10% Owner) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
| Acquired warrants
@ $5, valued at
$0 Acquired convertible notes
@ $5, valued at
$0 |
|
07/26/2016 |
4
| Griffin Noreen (CEO) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
| Bought 3,000,000 shares
@ $0 |
|
07/22/2016 |
4
| Pearce Christopher (COO) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
| Acquired 1,000,000 shares
@ $0 |
|
07/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/06/2016 |
4
| Akin Paul (Director) has filed a Form 4 on Immune Therapeutics, Inc. |
04/13/2016 |
4
| Selsky Clifford (Director) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
| Acquired 250,000 shares
@ $0 |
|
03/30/2016 |
4
| Griffin Noreen (CEO) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
| Acquired 500,000 shares
@ $0 Disposed of 1,000,000 shares
@ $0 |
|
03/30/2016 |
4
| Griffin Noreen (CEO) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
| Acquired 1 options to buy
@ $0.2, valued at
$0.2 |
|
03/30/2016 |
4
| Pearce Christopher (COO) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
| Acquired 1 options to buy
@ $0.2, valued at
$0.2 |
|
02/17/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/16/2015 |
4
| ARONSTAM PETER (CFO) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
| Granted 250,000 warrants
@ $0.14, valued at
$35k
|
|
01/15/2015 |
4
| BUTTA VINCENT (Director) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
| Granted 1,250,000 shares
@ $0 |
|
01/15/2015 |
4
| ELLIOTT SETH (PRESIDENT/ COO) has filed a Form 4 on Immune Therapeutics, Inc.
Txns:
| Granted 1,250,000 shares
@ $0 |
|
10/02/2014 |
4
| Pearce Christopher (COO) has filed a Form 4 on TNI BIOTECH, INC.
Txns:
| Acquired 500,000 shares
@ $0 |
|
10/02/2014 |
4
| Griffin Noreen (CEO) has filed a Form 4 on TNI BIOTECH, INC.
Txns:
| Acquired 328,701 shares
@ $0.1, valued at
$32.9k
Acquired 504,009 shares
@ $0.1, valued at
$50.4k
|
|
|
|